Dupilumab reduces systemic corticosteroid exposure in children with uncontrolled moderate-to-severe asthma regardless of prior exacerbations

被引：0

作者：

Hamelmann, Eckard ^{[1
]}

Deschildre, Antoine ^{[2
]}

Ducharme, Francine M. ^{[3
,4
,5
]}

Sher, Lawrence D. ^{[6
]}

De Mir, Ines ^{[7
]}

Xia, Changming ^{[8
]}

Gall, Rebecca ^{[8
]}

Ledanois, Olivier ^{[9
]}

Jacob-Nara, Juby A. ^{[10
]}

Sacks, Harry ^{[8
]}

Rowe, Paul J. ^{[10
]}

Deniz, Yamo ^{[10
]}

机构：

[1] Univ Bielefeld, Childrens Ctr Bethel, Dept Pediat, Bielefeld, Germany

[2] Univ Lille, CHU Lille, Pediat Allergy & Pulm Dept, Lille, France

[3] Dept Pediat, Montreal, PQ, Canada

[4] Dept Social, Montreal, PQ, Canada

[5] Dept Prevent Med, Montreal, PQ, Canada

[6] Peninsula Res Assoc, Rolling Hills Estates, CA USA

[7] Hosp Valle De Hebron, Barcelona, Spain

[8] Regeneron Pharmaceut Inc, Tarrytown, NY USA

[9] Sanofi, Paris, France

[10] Sanofi, Bridgewater, MA USA

来源：

关键词：

D O I：

10.1183/13993003.congress-2023.PA2101

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

PA2101

引用

页数：3